Alexion Pharmaceuticals, Inc. EBIT Margin 2010-2021 | ALXN

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Alexion Pharmaceuticals, Inc. (ALXN) over the last 10 years. The current EBIT profit margin for Alexion Pharmaceuticals, Inc. as of March 31, 2021 is .
EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
2021-03-31 $6.26B $0.57B 9.15%
2020-12-31 $6.07B $0.63B 10.43%
2020-09-30 $5.86B $0.55B 9.41%
2020-06-30 $5.54B $0.40B 7.17%
2020-03-31 $5.30B $2.30B 43.44%
2019-12-31 $4.99B $2.12B 42.51%
2019-09-30 $4.74B $1.62B 34.30%
2019-06-30 $4.50B $1.45B 32.30%
2019-03-31 $4.34B $0.52B 11.98%
2018-12-31 $4.13B $0.27B 6.53%
2018-09-30 $3.91B $0.34B 8.56%
2018-06-30 $3.75B $0.06B 1.50%
2018-03-31 $3.61B $0.68B 18.90%
2017-12-31 $3.55B $0.63B 17.68%
2017-09-30 $3.47B $0.65B 18.60%
2017-06-30 $3.41B $0.75B 21.83%
2017-03-31 $3.25B $0.71B 21.92%
2016-12-31 $3.08B $0.67B 21.63%
2016-09-30 $2.95B $0.64B 21.56%
2016-06-30 $2.82B $0.61B 21.72%
2016-03-31 $2.71B $0.60B 22.14%
2015-12-31 $2.60B $0.54B 20.62%
2015-09-30 $2.50B $0.64B 25.73%
2015-06-30 $2.39B $0.73B 30.36%
2015-03-31 $2.27B $0.76B 33.70%
2014-12-31 $2.23B $0.87B 38.94%
2014-09-30 $2.08B $0.80B 38.73%
2014-06-30 $1.92B $0.70B 36.54%
2014-03-31 $1.78B $0.62B 34.91%
2013-12-31 $1.55B $0.53B 34.04%
2013-09-30 $1.43B $0.50B 34.83%
2013-06-30 $1.32B $0.51B 38.22%
2013-03-31 $1.23B $0.45B 36.78%
2012-12-31 $1.14B $0.41B 35.68%
2012-09-30 $1.04B $0.37B 35.70%
2012-06-30 $0.95B $0.30B 30.99%
2012-03-31 $0.86B $0.26B 30.13%
2011-12-31 $0.78B $0.23B 29.34%
2011-09-30 $0.71B $0.20B 28.09%
2011-06-30 $0.65B $0.18B 27.23%
2011-03-31 $0.59B $0.16B 27.12%
2010-12-31 $0.54B $0.15B 27.86%
2010-09-30 $0.50B $0.13B 25.96%
2010-06-30 $0.46B $0.11B 24.89%
2010-03-31 $0.42B $0.10B 24.29%
2009-12-31 $0.39B $0.09B 22.74%